1-8 of 8
Anthonie WA Lensing
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rivaroxaban for Treatment of Pediatric Venous Thromboembolism. an Einstein-Jr Phase 3 Dose-Exposure-Response Evaluation

Guy Young, MD, Anthonie WA. Lensing, MD PhD, Paul Monagle, MBBS, MSc, Christoph Male, MD, Dagmar Kubitza, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 164.
https://doi.org/10.1182/blood-2019-124873
Published: 2019
Journal Articles

Meta-Analysis of Long-Term Risk of Recurrent Venous Thromboembolism after Stopping Anticoagulation in Men and Women with First Unprovoked Venous Thromboembolism

Faizan Khan, BSc, Alvi Rahman, MSc, Marc Carrier, MD MSc, Clive Kearon, MB, PhD, Jeffrey I. Weitz, MD, Sam Schulman, MD PhD FRCPC, Francis Couturaud, MD PhD, Sabine Eichinger, MD, Paul Alexander Kyrle, MD, Cecilia Becattini, MD PhD, Giancarlo Agnelli, MD, Timothy Brighton, MD, Anthonie WA. Lensing, MD PhD, Martin H. Prins, MD PhD, Elham Sabri, MSc, Brian Hutton, PhD, Laurent Pinede, MD PhD, Mary Cushman, MD MSc, Gualtiero Palareti, MD, George Wells, PhD, Paolo Prandoni, MD PhD, Harry R. Büller, MD PhD, Marc A. Rodger, MD MSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 2527.
https://doi.org/10.1182/blood-2018-99-113589
Published: 2018
Journal Articles

Healthcare Cost Impact of Continued Anticoagulation Therapy with Rivaroxaban Versus Aspirin for Prevention of Recurrent Symptomatic Venous Thromboembolism in the Einstein Choice Trial Population

Bruce L. Davidson, MD MPH, Philip S. Wells, MD FRCPC, MSc, Martin H. Prins, MD PhD, Jan Beyer-Westendorf, MD, Anthonie WA. Lensing, MD PhD, Lloyd Haskell, MD, Bennett Levitan, MD PhD, François Laliberté, Veronica Ashton, MPH, Yongling Xiao, PhD, Dominique Lejeune, Concetta Crivera, Patrick Lefebvre, MA, Qi Zhao, MPH, Zhong Yuan, MD PhD, Jeff Schein, Paolo Prandoni, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 218.
https://doi.org/10.1182/blood.V130.Suppl_1.218.218
Published: 2017
Journal Articles

Statin Use Was Associated With a Non-Significant Reduction In The Observed Incidence Of Recurrent VTE In Einstein-DVT and Einstein-PE

Martin Gebel, PhD, Martin Prins, MD, Anthonie WA Lensing, MD
Journal: Blood
Blood (2013) 122 (21): 1135.
https://doi.org/10.1182/blood.V122.21.1135.1135
Published: 2013
Journal Articles

Performance Of The Simplified Pesi Score In Patients With Pulmonary Embolism Treated With Rivaroxaban Or Standard Therapy

Petra MG Erkens, PhD, Gregory J Fermann, MD, FACEP, Martin H Prins, MD, Philip S Wells, MD, MSc, Akos F Pap, MSc, Anthonie WA Lensing, MD
Journal: Blood
Blood (2013) 122 (21): 1139.
https://doi.org/10.1182/blood.V122.21.1139.1139
Published: 2013
Journal Articles

Reduction in Initial Length of Stay with Rivaroxaban Single-Drug Regimen versus LMWH-VKA Standard of Care: Findings from the EINSTEIN Trial Program

Bonno van Bellen, MD, Martin Prins, MD, PhD, Luke Bamber, Maria Wang, Anthonie WA Lensing
Journal: Blood
Blood (2012) 120 (21): 3419.
https://doi.org/10.1182/blood.V120.21.3419.3419
Published: 2012
Journal Articles

Patient-Reported Treatment Satisfaction with Oral Rivaroxaban Versus Standard Therapy in the Treatment of Acute Symptomatic Pulmonary Embolism

Martin Prins, MD, PhD, Luke Bamber, Stefan Cano, Maria Wang, Anthonie WA Lensing, Rupert Bauersachs
Journal: Blood
Blood (2012) 120 (21): 1163.
https://doi.org/10.1182/blood.V120.21.1163.1163
Published: 2012
Journal Articles

The EINSTEIN DVT Study: Does Localization of the Initial DVT Affect the Occurrence of Recurrent VTE While Patients Are on Anticoagulation?

Martin H Prins, Paolo Prandoni, Anthonie WA Lensing, Bonno van Bellen, Akos F Pap, Gary E Raskob, Harry R Büller
Journal: Blood
Blood (2011) 118 (21): 207.
https://doi.org/10.1182/blood.V118.21.207.207
Published: 2011